retatrutide benefits study Eli Lilly's shows promising weight loss results in phase 3 trial ✨ RETATRUTIDE — The Next

chronic weight management in individuals with obesity or overweight

Results will be noticeably compromised

The following body weight changes were observed with different doses of the medication: Retatrutide benefits beyond weight loss: Exploring other potential benefits The same phase 2 clinical trials demonstrate that retatrutide also improved the cardiometabolic profiles of patients

Only 5 patients stopped the trial from gastrointestinal side effects and only 5% of the 9mg and 12mg arms had to stop the trial for any adverse events

GLP-1 medications are typically used as a long-term treatment for weight management

In addition to behavioral preservation, the study also determined that the number of synapses remained unchanged and the number of plaques and amyloid oligomers decreased, all physical indications against neurodegeneration [61]